Long-term mortality following bloodstream infection

Clinical Microbiology and Infection

Volumn 19, Issue 10, 2013, Pages 955-960

  Lillie, P J ^a   Allen, J ^a   Hall, C ^a   Walsh, C ^a   Adams, K ^a   Thaker, H ^a   Moss, P ^a   Barlow, G D ^a  

^a CASTLE HILL HOSPITAL   (United Kingdom)

Author keywords

Bacteraemia; Co morbidity; Fever; Long term; Mortality

Indexed keywords

ALBUMIN; SERUM ALBUMIN; UREA;

ADULT; AGED; ARTICLE; BACTEREMIA; BLOODSTREAM INFECTION; CHRONIC KIDNEY DISEASE; CLINICAL STUDY; CONSULTATION; DEATH; FEMALE; FOLLOW UP; HEALTH SERVICE; HUMAN; HYPOTHERMIA; LABORATORY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK; SURVIVAL RATE; TEMPERATURE; VASCULAR DISEASE;

BACTERAEMIA; CO-MORBIDITY; FEVER; LONG-TERM; MORTALITY;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BACTEREMIA; BODY TEMPERATURE; COHORT STUDIES; COMORBIDITY; FEMALE; GREAT BRITAIN; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS;

EID: 84884705640     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12101     Document Type: Article

References (22)

1. Leibovici L, Samra Z, Konigsberger H, Drucker M, Ashkenazi S, Pitlik SD. Long-term survival following bacteremia or fungemia. JAMA 1995; 274: 807-812.
2. Bates DW, Pruess KE, Lee TH. How bad are bacteremia and sepsis? Outcomes in a cohort with suspected bacteremia Arch Intern Med 1995; 155: 593-598.
3. Laupland KB, Svenson LW, Gregson DB, Church DL. Long-term mortality associated with community-onset bloodstream infection. Infection 2011; 39: 405-410.
4. Hounsom L, Grayson K, Melzer M. Mortality and associated risk factors in consecutive patients admitted to a UK NHS trust with community acquired bacteraemia. Postgrad Med J 2011; 87: 757-762.
5. Hanses F, Spaeth C, Ehrenstein BP, Linde HJ, Scholmerich J, Salzberger B. Risk factors associated with long-term prognosis of patients with Staphylococcus aureus bacteremia. Infection 2010; 38: 465-470.
6. Lillie P, Moss P, Thaker H et al. Development, impact and outcomes of the Hull Bacteraemia Service. QJM 2008; 101: 889-898.
7. Wyllie DH, Crook DW, Peto TE. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ 2006; 333: 281.
8. Fatkenheuer G, Preuss M, Salzberger B et al. Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 2004; 23: 157-162.
9. Elston JW, Santaniello-Newton A, Meigh JA et al. Increasing incidence of invasive pneumococcal disease and pneumonia despite improved vaccination uptake: surveillance in Hull and East Yorkshire, UK, 2002-2009. Epidemiol Infect 2012; 140: 1252-1266.
10. Phillips A, Shaper AG, Whincup PH. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 1989; 2: 1434-1436.
11. Rifkin DE, Katz R, Chonchol M et al. Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly. Nephrol Dial Transplant 2010; 25: 1560-1567.
12. Rifkin DE, Shlipak MG, Katz R et al. Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 2008; 168: 2212-2218.
13. Thomsen RW, Hundborg HH, Johnsen SP et al. Statin use and mortality within 180 days after bacteremia: a population-based cohort study. Crit Care Med 2006; 34: 1080-1086.
14. Ridker PM, MacFadyen J, Libby P, Glynn RJ. Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). Am J Cardiol 2010; 106: 204-209.
15. Kaptoge S, Di Angelantonio E, Lowe G et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010; 375: 132-140.
16. Lee BH, Inui D, Suh GY et al. Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study. Crit Care 2012; 16: R33.
17. Barlow G, Lillie P, Nathwani D, Davey P. Fever as nature's engine. Some clinical data. BMJ 2010; 340: c905. Epub 2010/02/18.
18. Van Dissel JT, Numan SC, Van't Wout JW. Chills in 'early sepsis': good for you? J Intern Med 2005; 257: 469-472.
19. Rieg S, Peyerl-Hoffmann G, de With K et al. Mortality of S. aureus bacteremia and infectious diseases specialist consultation-a study of 521 patients in Germany. J Infect 2009; 59: 232-239.
20. Minton J, Clayton J, Sandoe J, Mc Gann H, Wilcox M. Improving early management of bloodstream infection: a quality improvement project. BMJ 2008; 336: 440-443.
21. Jenkins TC, Price CS, Sabel AL, Mehler PS, Burman WJ. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis 2008; 46: 1000-1008.
22. Robinson JO, Pozzi-Langhi S, Phillips M et al. Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia. Eur J Clin Microbiol Infect Dis 2012; 31: 2421-2428.